Clinical trial

Angiotensin II in General Anesthesia

NCT03733145

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-10-03

PhasePHASE4

Study timeline

Study start (actual)2019-10-03Date precision: day

Registry last updated2025-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

Angiotensin IIDRUG · verified · RxNorm: angiotensin II

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

National Institute on Aging (NIA)collaborator

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03733145 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.